Acute and continuation therapy in unipolar depression: Observations from the run-in phase of a maintenance trial

Acta Psychiatrica Scandinavica

Volumn 118, Issue 2, 2008, Pages 123-129

  Gram, L F ^b   Rasmussen, N A ^a   Andersen, P M ^a   Licht, R W ^a   Klaning U ^a   Egander, A ^a   Abildgaard, W ^a   Richelsen, B ^a   Stadil, B ^a   Clemmensen, K ^a   Reiner, M ^a   Vestergaard, P ^a   Hausmann, G ^a   Kristensen, J ^a   Molgaard K ^a   Malling, B ^a   Jensen, C Z ^a   Olsen, M ^b   Egersgard J ^b   Stage, K B ^b   Christoffersen, J ^b   Bendsen, B B ^c   Larsen, J K ^c,e   Watjen I ^c   Holgersen, B ^d   Jensen, B M ^d   Christensen, M B ^d   Andersson, J E ^d   Wedervang Jensen, T ^e   Clemmensen, P ^e   Kayser, C ^e   Bock, C ^e   Andersen, J ^f   Nalders, K ^f   Frederiksen, K ^f   Andersen, M ^f   Christensen, E M ^g   Johansen, A M ^g   Martiny, K ^g   Borup, H ^h   Thomsen, I S ^h   Matzen, P ^h   Kragh Sorensen P ^b   Gjerris, A ^e   Bech, P ^g   Rosenkrantz De Lasson, A ⁱ   Ledderer, L ⁱ   Horneberg, H ⁱ   more..

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f Department of Psychiatry   (Denmark)

^g HILLERØD HOSPITAL   (Denmark)

^h AALBORG UNIVERSITY HOSPITAL   (Denmark)

ⁱ NONE

Author keywords

Antidepressant agents; Major depressive disorder; Psychotropic drugs; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; HYPNOTIC SEDATIVE AGENT; LITHIUM; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEUROLEPTIC AGENT; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MULTICENTER STUDY; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; RELAPSE; REMISSION; SUICIDAL BEHAVIOR; TREATMENT OUTCOME; URINE RETENTION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DENMARK; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

EID: 46949087456     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01182.x     Document Type: Article

References (34)

1. Angst J lf_gram@yahoo.com. A regular review of the long term follow up of depression. BMJ 1997 315 : 1143 1146.
2. Paykel ES. Continuation and maintenance therapy in depression. Br Med Bull 2001 57 : 145 159.
3. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harvard Rev Psychiatry 1998 5 : 293 306.
4. Geddes JR, Carney SM, Davies C et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003 361 : 653 661.
5. Gelenberg AJ, Chesen CL. How fast are antidepressants? J Clin Psychiatry 2000 61 : 712 721.
6. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995 25 : 1171 1180.
7. Ananth J. Treatment-resistant depression. Psychother Psychsom 1998 67 : 61 70.
8. Souery D, Amsterdam J, de Montigny C et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 1999 9 : 83 91.
9. Costa e Silva JA, Freeman HL (eds). Dysthymia in clinical practice. Acta Psychiatr Scand 1994 89 (Suppl. 383 50.
10. Keller MB, Shapiro RW. "Double depression": Superimpostion of acute depressive episodes on chronic depressive disorder. Am J Psychiatry 1982 139 : 438 442.
11. Koscis JH. Pharmacotherapy for chronic depression. J Clin Psychology 2003 59 : 885 892.
12. Scott J. Treatment of chronic depression. N Engl J Med 2000 342 : 1518 1520.
13. Khan A, Detke M, Khan SR, Mallinckrodt C. Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis 2003 191 : 211 218.
14. Yang H, Cusin C, Fava M. Is there a placebo problem in antidepressant trials? Curr Top Med Chem 2005 5 : 1077 1088.
15. Keitner GI, Posternak MA, Rayan CE. How many subjects with major depressive disorder meet the eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry 2003 64 : 1091 1093.
16. Danish University Antidepressant Group. Citalopram; clinical effect profile in comparison with clomipramine. - a controlled multicenter study. Psychopharmacology 1986 90 : 131 138.
17. Danish University Antidepressant Group. Paroxetine; a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine - a controlled multicenter study. J Affect Disord 1993 18 : 289 299.
18. WHO. SCAN - schedules for clinical assessment in neuropsychiatry : Version 2.0. Geneva : Division of Mental Health, World Health Organization, 1994.
19. WHO. The ICD-10 classification of mental and behavioral disorders - diagnostic criteria for research. Geneva : Division of Mental Health. World Health Organization, 1993.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967 6 : 278 296.
21. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium Acta Psychiatr Scand 1986 73 (suppl. 326 1 37.
22. Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975 51 : 161 170.
23. Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and prediction of ECT response. Br J Psychiatry 1965 111 : 659 674.
24. Gurney C. Diagnostic scales for affective disorder Mexico City : Abstract from the World Conference on Psychiatry, 1971 : 330 P. Rating scales for psychopathology, health status and quality of life. Berlin : Springer Verlag, 1993.
25. Gram LF. Fluoxetine. N Engl J Med 1994 331 : 1354 1361.
26. Danish University Antidepressant Group. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Clin Pharmacol Ther 1999 66 : 152 165.
27. Siegel S, Castellan NJ. Non parametric statistics for the behavioral sciences, 2nd edn. New York : McGraw-Hill, 1988, 399.
28. Wulff HR, Sclichting P. MedStat statistical program, version 2.12 Albertslund, Denmark : Astra Group A/S, 1991.
29. Rush AJ, Trivedi MH, Wisniewski SR et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006 163 : 1905 1917.
30. Rush AJ. STAR*D: What have we learned? Am J Psychiatry 2007 164 : 201 204.
31. Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 2006 188 : 410 415.
32. Bauer M, Crossley NA, Gerber S, Bschor T. The acute antidepressive effect of lithium: from monotherapy to augumentation. In : Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in psychiatry. The comprehensive guide. Abingdon : Informa Healthcare, 2006 : 109 128.
33. Hansen DG, Søndergaard J, Vach W, Gram LF, Rosholm JU, Kragstrup J. Antidepressant drug use in general practice: Inter-practice variation and association with practice characteristics. Eur J Clin Pharmacol 2003 59 : 143 49.
34. Anderson IM, Nutt DJ, Deakin JFW. Evidence-based guidelines for treating depressive disorder with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 2000 14 : 3 20.